XBP1 and hepatocellular carcinoma: Based on the evidence, we propose that sorafenib reduces cell viability and induces cell apoptosis via downregulation of AGR2 in the cell lysate and increased secretion in CM, which induces ER stress via upregulation of p-IRE1α and spliced XBP1 in HCC.